For the first time, researchers at the Technical University of Munich (TUM) have succeeded in using nanorobots to stimulate ...

Gallant is developing FDA-regulated, off-the-shelf mesenchymal stromal cell therapies to rapidly modulate inflammation, support tissue repair, and make stem cell treatment broadly available to cats ...

A research team in South Korea has successfully developed a novel technology that combines nanoparticles with stem cells to ...

In a recent study published in Scientific Reports, researchers discuss the results of a multicentric, randomized, placebo-controlled trial to determine the safety and efficacy of normoxic-allogenic ...

Asan Medical Center in Seoul has transferred its stem cell therapy technology, developed for the treatment of intractable ...

Sanjeev Luther, President and CEO to give an oral presentation and participate in a moderated panel discussionCAMBRIDGE, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an ...

More than 4 million people worldwide have end-stage kidney disease that requires hemodialysis, a treatment in which a machine filters waste from the blood. Hemodialysis is a precursor to kidney ...

Credit: Getty Images. NurOwn consists of autologous mesenchymal stem cells that have been induced to secrete neurotrophic factors. The Food and Drug Administration (FDA)’s Cellular, Tissue and Gene ...

Neoadjuvant FOLF(IRIN)OX Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Multicenter Randomized Noncomparative Phase II Trial (PANACHE01 FRENCH08 PRODIGE48 study) The aim of this open-label, ...

More than 4 million people worldwide have end-stage kidney disease that requires hemodialysis, a treatment in which a machine filters waste from the blood. Hemodialysis is a precursor to kidney ...